(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

34 trials 19 recruiting VVarious

Filter these 34 trials by condition, phase, country and more.

Open in Search →
34 Registered trials
19 Recruiting
4 Completed trials
20 Sponsors
7 Countries
Phase III: 1 Phase II/III: 2 Phase II: 24 Phase I/II: 3 Phase III/IV: 2 Phase IV: 1 Phase I (Other): 1

Indications tested

Triple negative breast cancer 3 Cholangiocarcinoma 1 Pleural mesothelioma 1 Ovarian cancer 1 Giant cell arteritis 1 Gastric cancer 1 Polymyalgia rheumatica 1

Sponsors using this IMP

Institut Curie 5 Universitair Medisch Centrum Groningen 4 Aalborg University Hospital 3 Rigshospitalet 3 Centre Hospitalier Universitaire De Bordeaux 2 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 2 University Hospital Maastricht 2 Academisch Ziekenhuis Maastricht 1 Amsterdam UMC Stichting 1 Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico 1 Centre Hospitalier Regional Et Universitaire De Brest 1 Centre Hospitalier Universitaire De Nantes 1

All trials

34 total

Showing 1–24 of 34 trials

← All drugs A–Z